Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion type Assertion NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_head.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion description "[Overall, erbB2-positive patients had a significantly lower recurrence-free probability than others, 62% at five years as compared to 83%, and showed a significantly decreased breast cancer survival rate (P = 0.0007).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion evidence source_evidence_literature NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion SIO_000772 11205461 NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion wasDerivedFrom befree-2016 NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.
- NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_assertion wasGeneratedBy ECO_0000203 NP308387.RAyMM0fDzyG3nJkQ8KzWrDsU7On6u2nbf0v-bM1WPai6s130_provenance.